<DOC>
	<DOCNO>NCT02477579</DOCNO>
	<brief_summary>This study evaluate safety effectiveness novel device call NovaCross help cross Chronic Total Occlusion ( CTO ) lesion coronary artery .</brief_summary>
	<brief_title>A Prospective , Multi-Center , Pivotal Study Evaluate Safety Effectiveness NovaCross™ Micro-catheter Facilitating Crossing Chronic Total Occlusion ( CTO ) Coronary Lesions</brief_title>
	<detailed_description>The purpose trial evaluate safety effectiveness NovaCross™ micro-catheter use facilitate cross Chronic Total Occlusion ( CTO ) lesion coronary artery . The procedure conduct consent patient diagnose CTO coronary vessel require revascularization previously fail attempt cross refractory 10 minute conventional guidewire attempt .</detailed_description>
	<criteria>Adult age 2580 Patient understands sign study inform consent form . Patient angiographic document Chronic Total Occlusion ( i.e . &gt; 3 month occlusion duration ) show distal TIMI flow 0 . Suitable candidate nonemergent , coronary angioplasty Documented coronary angiography precede PCI reveals least one CTO lesion situate noninfarct related coronary artery side branch Body Mass Index ( BMI ) &lt; 40 Left ventricle ejection fraction &gt; 25 % Patient unable give inform consent . Current participation another study investigational drug device . Patient know suspected tolerate contrast agent . Aortaostial CTO location ( Ostial bifurcation origin may consider ) , SVG CTO , instent CTO . Intolerance Aspirin and/or inability tolerate second antiplatelet agent ( Clopidogrel Prasugrel Ticagrelor ) . Appearance fresh thrombus intraluminal filling defect . Recent major cerebrovascular event ( history stroke TIA within 1 month ) Cardiac intervention within 4 week procedure Renal insufficiency ( serum creatinine &gt; 2.3mg/dl 203μmol/L ) Active gastrointestinal bleeding Active infection fever may due infection Life expectancy &lt; 2 year due illness Significant anemia ( hemoglobin &lt; 8.0 mg / dl ) Severe uncontrolled systemic hypertension ( &gt; 240 mmHg within 1 month procedure ) Severe electrolyte imbalance Congestive heart failure [ New York Heart Association ( NYHA ) Class III\IV ] CSA Class IV . Unstable angina require emergent percutaneous transluminal coronary angioplasty ( PTCA ) coronary artery bypass graft ( CABG ) Recent myocardial infarction ( MI ) ( within past two week ) Uncontrolled diabetes &gt; 2 serum glucose concentration &gt; 350 mg/dl within 7 day . Unwillingness inability comply protocol requirement Pregnant nursing Extensive prior dissection coronary guidewire use Drug abuse alcoholism . Patients custodial care . Bleeding diathesis coagulation disorder ; Kawasaki 's disease vasculitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>